Psychoactive drugs

Braxia Scientific CEO, Chief Medical Officer Awarded $918,000 by Canadian Government to Study Benefits of Integrating Ketamine with Cognitive Behavioural Therapy to Reduce Suicidality

Retrieved on: 
Wednesday, July 28, 2021
Psychoactive drugs, Drugs, Clinical medicine, Sedatives, Psychiatric diagnosis, Addiction, Addiction medicine, Cognitive behavioral therapy, Ketamine, Major depressive disorder, Behaviour therapy, Suicide

The funding will be used to evaluate the effectiveness of intravenous ketamine, in combination with internet-based cognitive behavioural therapy (iCBT), to rapidly reduce suicidality in persons with depression, when compared to iCBT alone.

Key Points: 
  • The funding will be used to evaluate the effectiveness of intravenous ketamine, in combination with internet-based cognitive behavioural therapy (iCBT), to rapidly reduce suicidality in persons with depression, when compared to iCBT alone.
  • It is separately reported in the biomedical literature that cognitive behavioural therapy may also reduce suicidality, but requires several weeks to months before reductions in suicidality are significant.
  • "Integrating ketamine with CBT provides an opportunity to rapidly reduce suicidality and sustain the effect over the long term.
  • Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders.

Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application

Retrieved on: 
Wednesday, July 28, 2021
Psychoactive drugs, Drugs, Neurochemistry, Antidepressants, NMDA receptor antagonists, Dissociative drugs, Nicotinic antagonists, Sedatives, Ketamine, Nutraceutical, Psychedelic drug

The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Key Points: 
  • The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.
  • Todays announcements are further evidence of the synergies between our growing clinic network and our contract research offerings, said Ketamine Ones Interim CEO, Adam Deffett.
  • We view this as a great opportunity to demonstrate their operational capabilities while also earning a new revenue stream from Ketamine One, added Mr. Deffett.
  • As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy.

Shatterizer inc. launches their newest edition to the family, the BUBBLER by Shatterizer

Retrieved on: 
Wednesday, July 28, 2021
Cannabis smoking, Psychoactive drugs, Health sciences, Pharmacology, Euphoriants, Drug paraphernalia, Dosage forms, Cannabis, Vaporizer, Bubbler

Toronto, ON, July 28, 2021 (GLOBE NEWSWIRE) -- Shatterizer inc. is pleased to announce their revolutionary portable and desktop cannabis extracts vaporizer, the BUBBLER by Shatterizer .

Key Points: 
  • Toronto, ON, July 28, 2021 (GLOBE NEWSWIRE) -- Shatterizer inc. is pleased to announce their revolutionary portable and desktop cannabis extracts vaporizer, the BUBBLER by Shatterizer .
  • In 2021, Shatterizer aims to surpass expectations with their newest product, the BUBBLER by Shatterizer .
  • The BUBBLER by Shatterizer is the most innovative cannabis concentrate vaporizer to hit the market.
  • We believe in delivering market disrupting products, and we personally love the BUBBLER by Shatterizer, expect even more #PerfectClouds in 2021!

CampNova Announces Sourcing and Retail Partnerships for 2 Chainz' GAS Cannabis Brand

Retrieved on: 
Wednesday, July 28, 2021
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Psychoactive drugs, Medicine

LOS ANGELES, July 28, 2021 /PRNewswire/ -- CampNova has created a partnership with titan cannabis cultivator, Vertical Companies, to source premium cannabis flower for 2 Chainz' GAS Cannabis brands .

Key Points: 
  • LOS ANGELES, July 28, 2021 /PRNewswire/ -- CampNova has created a partnership with titan cannabis cultivator, Vertical Companies, to source premium cannabis flower for 2 Chainz' GAS Cannabis brands .
  • The technology platform also announced Hellapax and Smoke on the Water as the primary delivery service exclusively for GAS Cannabis.
  • The definitive agreements call for a strategic partnership expected to accelerate the access and availability of GAS Cannabis in CampNova's direct-to-consumer strategies.
  • The goal of both companies is to further align other delivery and retail partnerships while creating more minority business partnerships with GAS Cannabis .

Collective Project Launches Lineup of Cannabis-Infused Craft Beverages

Retrieved on: 
Tuesday, July 27, 2021
Psychoactive drugs, Cannabis smoking, Cannabis, Entheogens, Herbalism, Cocktail, Tea, Juice, Effects of cannabis

Hamilton, Ontario, July 27, 2021 (GLOBE NEWSWIRE) -- Collective Project has developed a brand-new range of Cannabis-infused beverages now available at OCS.ca.

Key Points: 
  • Hamilton, Ontario, July 27, 2021 (GLOBE NEWSWIRE) -- Collective Project has developed a brand-new range of Cannabis-infused beverages now available at OCS.ca.
  • Collective Project beverage combines fresh juices, real botanicals and high-quality cannabis emulsions for an unparalleled flavour profile and drinking experience.
  • Collective Project teas and juices include a diverse portfolio of doses that may be suitable for a variety of consumers.
  • Made with real ingredients and an emulsion of 10mg THC & 10mg CBD
    Collective Project adds to Collective Arts growing lineup of over 150 annual beverage releases including craft beer, ready-to-drink cocktails and sparkling hard teas.

New to The Street Signs 12 Part TV Series To Feature Global Wellness Strategies, Inc.; Filming Started Week of July 26, 2021

Retrieved on: 
Tuesday, July 27, 2021
Psychoactive drugs, Drugs, Entheogens, Euphoriants, Herbalism, Medicinal plants, Cannabis, Cannabis smoking, MDMA, Hemp, Newsmax

Throughout the series, Ms. Kott introduces the companys other subsidiaries which produce hemp and medicinal-mushroom infused CBD products for consumers .

Key Points: 
  • Throughout the series, Ms. Kott introduces the companys other subsidiaries which produce hemp and medicinal-mushroom infused CBD products for consumers .
  • Global Wellness Strategies, Inc. offers a range of MDMA-based novel treatments that we believe can solve the chronic pain problems of millions.
  • Filming begins later the week of July 26, 2021 with New to The Street host Jane King .
  • The Newsmax New to The Street TV show is syndicated on Sundays at 10 AM EST.

Texas Original Compassionate Cultivation Opens New Prescription Pick-Up Location in North Austin

Retrieved on: 
Tuesday, July 27, 2021
Other Health, Health, General Health, Women, Seniors, Pharmaceutical, Agriculture, MEN, Natural Resources, Fitness & Nutrition, Consumer, Cannabis, Drugs in the United States, Psychoactive drugs, Drug policy of the United States, Cannabis smoking, Entheogens, Legality of cannabis

Texas Original Compassionate Cultivation (TOCC), Texas leading medical cannabis provider, today announced the opening of its North Austin prescription pick-up location.

Key Points: 
  • Texas Original Compassionate Cultivation (TOCC), Texas leading medical cannabis provider, today announced the opening of its North Austin prescription pick-up location.
  • The addition of the North Austin site extends TOCCs footprint even farther, offering patients and caregivers in Central Texas another accessible option to acquire their cannabis medicines.
  • Our pick-up locations are made possible due to our strategic relationships with physicians and organizations throughout the state of Texas, said Morris Denton, TOCCs CEO.
  • Texas Original Compassionate Cultivation (TOCC) is the leading licensed medical marijuana producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state.

Lyndra Therapeutics’ Investigational Oral, Weekly Opioid Use Disorder Treatment LYN-014 Granted Fast Track Designation by FDA

Retrieved on: 
Tuesday, July 27, 2021
Mental health, FDA, Health, Clinical trials, Pharmaceutical, Biotechnology, Drug rehabilitation, Drugs, Psychoactive drugs, Synthetic opioids, Ketones, Substance dependence, Medical specialties, Euphoriants, Methadone, Levomethadone, Opioid use disorder, Opioid, LYN-014, Opioid Use Disorder, Lyndra Therapeutics, LYN-014, OPIOID USE DISORDER, LYNDRA THERAPEUTICS

A weekly dosage form would free people from daily trips to methadone clinics and support consistency of treatment, recovery and wellbeing.

Key Points: 
  • A weekly dosage form would free people from daily trips to methadone clinics and support consistency of treatment, recovery and wellbeing.
  • The FDAs decision to grant LYN-014 Fast Track designation speaks to their commitment to provide people living with OUD with new, innovative treatment options.
  • LYN-014, which was granted investigational new drug status in April, is set to begin a Phase 1 clinical trial this quarter.
  • LYN-014, Lyndras investigational oral, ultra-long-acting extended-release weekly levomethadone capsule, is being developed for the treatment of people living with opioid use disorder (OUD).

Legacy Cannabis Taffy Brand Cheeba Chews Debuts New Products That Boost Cannabinoid Wellness

Retrieved on: 
Tuesday, July 27, 2021
Alternative medicine, Retail, Health, Other Retail, Tobacco, Specialty, Psychoactive drugs, Cannabis smoking, Cannabis culture, Cannabis edible, Cannabis, Effects of cannabis

Legacy cannabis-infused edibles brand Cheeba Chews announced today the launch of its Wellness Line, integrating unique cannabinoid combinations into its nostalgic taffies.

Key Points: 
  • Legacy cannabis-infused edibles brand Cheeba Chews announced today the launch of its Wellness Line, integrating unique cannabinoid combinations into its nostalgic taffies.
  • To know how our wellness line is improving the daily routines of our customers is driving us to dive further into other cannabinoid innovations.
  • Sold in 20 packs, individuals can purchase the new Cheeba Chews wellness products in California, Colorado, Massachusetts, Nevada and Oklahoma.
  • Cheeba Chews products are currently available in medical and recreational markets in California, Colorado, Massachusetts, Nevada and Oklahoma.

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent

Retrieved on: 
Tuesday, July 27, 2021
Drugs, Euphoriants, Cannabinoid, Psychoactive drugs, Appetite stimulants, Entheogens, Yarrowia, Tetrahydrocannabinol, Patent, Branches of biology

SAN FRANCISCO, July 27, 2021 /PRNewswire/ -- Biomedican has received notification from the U.S. patent office that its first patent has been approved and will be issued in the coming months.

Key Points: 
  • SAN FRANCISCO, July 27, 2021 /PRNewswire/ -- Biomedican has received notification from the U.S. patent office that its first patent has been approved and will be issued in the coming months.
  • This is the first patent ever to be issued using Yarrowia Lipolytica to produce cannabinoids.
  • Enzymes which are converting CBGA into CBDA, CBCA and THCA are required for the presence of interaction of two phases: oil and water.
  • "Patenting the use of Yarrowia Lipolytica to produce cannabinoids gives Biomedican a significant competitive advantage in the biosynthesized cannabinoid market.